Humasis Co. Ltd. (KOSDAQ:205470)
South Korea · Delayed Price · Currency is KRW 759.00
+32.00 (4.40%)
Apr 3, 2026, 3:30 PM KST
Humasis Market Cap
Humasis has a market cap or net worth of 85.88 billion as of April 2, 2026. Its market cap has decreased by -52.29% in one year.
Market Cap
85.88B
Enterprise Value
-87.00B
Revenue
30.11B
Ranking
n/a
PE Ratio
n/a
Stock Price
759.00
Market Cap Chart
Since September 27, 2017, Humasis's market cap has increased from 10.76B to 85.88B, an increase of 697.94%. That is a compound annual growth rate of 27.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2026 | 85.88B | -25.15% |
| Dec 30, 2025 | 114.74B | -38.06% |
| Dec 30, 2024 | 185.23B | -22.80% |
| Dec 28, 2023 | 239.92B | -47.44% |
| Dec 29, 2022 | 456.45B | -20.07% |
| Dec 30, 2021 | 571.04B | 75.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 69.62T |
| Celltrion | 43.13T |
| Sam Chun Dang Pharm. | 19.28T |
| ALTEOGEN | 18.27T |
| IMB Dx | 90.84B |
| Oncocross | 89.64B |
| BIT Computer | 80.87B |
| PharmGen Science | 80.31B |